哮喘与阻塞性睡眠呼吸暂停重叠:证据带来的启示
综述探讨哮喘与阻塞性睡眠呼吸暂停(OSA)的相互影响。两者高患病率且共享危险因素,新兴证据表明白气道和全身炎症、神经免疫相互作用及哮喘控制药物(皮质类固醇)可能使哮喘患者易患OSA;反之,未诊断或治疗不充分的OSA通过间歇性缺氧影响气道炎症和组织重塑,不利于哮喘控制。文章还为临床医生提供建议并指出知识空白。
要点
- 哮喘与OSA常共存,且相互影响疾病严重程度。
- 皮质类固醇使用可能增加哮喘患者罹患OSA的风险。
- 未诊断或未充分治疗的OSA可恶化哮喘控制。
核心结论
- 哮喘与OSA存在双向相互作用,各自影响对方严重程度。
研究设计与样本
- 综述,检索近期发表的多种证据。
主要发现
- 气道和全身炎症、神经免疫相互作用及皮质类固醇使用可能易感OSA。
- 未诊断或治疗不充分的OSA通过间歇性缺氧影响气道炎症和组织重塑,恶化哮喘控制。
临床怎么用
- 为照护成人哮喘患者的临床医生提供建议。
- 识别关于哮喘与OSA重叠的关键知识空白。
局限性
- 识别了关于此重叠的关键知识空白。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Obstructive sleep apnea (OSA) and asthma are highly prevalent chronic respiratory disorders. Beyond their frequent coexistence arising from their high prevalence and shared risk factors, these disorders feature a reciprocal interaction whereby each disease impacts the severity of the other. Emerging evidence implicates airway and systemic inflammation, neuroimmune interactions, and effects of asthma-controlling medications (corticosteroids) as factors that predispose patients with asthma to OSA. Conversely, undiagnosed or inadequately treated OSA adversely affects asthma control, partly via effects of intermittent hypoxia on airway inflammation and tissue remodeling. In this article, we review multiple lines of recently published evidence supporting this interaction. We provide a set of recommendations for clinicians involved in the care of adults with asthma, and identify critical gaps in our knowledge about this overlap.
引用
- Prasad B, Nyenhuis SM, Imayama I, et al. Asthma and Obstructive Sleep Apnea Overlap: What Has the Evidence Taught Us? Am J Respir Crit Care Med. 2020. PMID: 31841642. doi:10.1164/rccm.201810-1838TR
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。